New Arthritis Drug Combo Shows Promise in Early Trial
Amplio Pharma reported positive Phase 1b results for NovoBioJect, designed to improve first-line rheumatoid arthritis treatment.
Simple explainers on world affairs, science, health and more.
All news under one minute
Amplio Pharma reported positive Phase 1b results for NovoBioJect, designed to improve first-line rheumatoid arthritis treatment.
Gain Therapeutics reported 12-month Phase 1b data for rexaceract in Parkinson's disease, with stable motor scores and no disease progression.
A CHOP survey found over 50% of pediatric health misinformation involved vaccines; researchers built a public tool to counter it.
A Sleep Medicine Reviews study of 1.3 million people found insomnia linked to 26% higher stroke risk and 28% higher odds of…
Notre Dame researchers found that belzutifan plus lab-made TRAIL protein can overcome resistance in aggressive clear cell kidney cancer.
A WHO-IARC study in The Lancet Oncology found infections caused 2.3 million cancers in 2024, about one in eight, with most cases…
From Artemis II sleep monitors to Mars simulation timing, NASA research shows how much sleep depends on timing, not just tiredness.
Mayo Clinic Proceedings study: astronauts with 90-plus-day spaceflights face higher hip fracture rates on Earth return.
Maharashtra Governor Jishnu Dev Varma urged youth to become TB awareness ambassadors at a walk in Andheri under the TB Mukt Mumbai…
India reported 3,832 new child leprosy cases in 2025-26, 91.6% above target; 37 had Grade-2 disability, signalling delayed detection.